These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20377810)

  • 1. Managing mixed dyslipidemia in special populations.
    Miller M
    Prev Cardiol; 2010; 13(2):78-83. PubMed ID: 20377810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe dyslipidemia and concomitant risk factors in the middle-aged Lithuanian adults: a cross-sectional cohort study.
    Kutkienė S; Petrulionienė Ž; Laucevičius A; Petrylaitė M; Maskeliūnaitė D; Puronaitė R; Kovaitė M; Kalibaitaitė I; Rinkūnienė E; Dženkevičiūtė V; Kasiulevičius V
    Lipids Health Dis; 2018 Apr; 17(1):88. PubMed ID: 29673349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Syndrome During Menopause.
    Mumusoglu S; Yildiz BO
    Curr Vasc Pharmacol; 2019; 17(6):595-603. PubMed ID: 30179134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dyslipidemia in the metabolic syndrome in children.
    Gidding SS
    J Cardiometab Syndr; 2006; 1(4):282-5. PubMed ID: 17679808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: Part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus.
    Ginsberg HN; MacCallum PR
    J Cardiometab Syndr; 2009; 4(2):113-9. PubMed ID: 19614799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology, trends, and morbidities of obesity and the metabolic syndrome.
    Bray GA; Bellanger T
    Endocrine; 2006 Feb; 29(1):109-17. PubMed ID: 16622298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Residential Greenness, Cardiometabolic Disorders, and Cardiovascular Disease Among Adults in China.
    Yang BY; Hu LW; Jalaludin B; Knibbs LD; Markevych I; Heinrich J; Bloom MS; Morawska L; Lin S; Jalava P; Roponen M; Gao M; Chen DH; Zhou Y; Yu HY; Liu RQ; Zeng XW; Zeeshan M; Guo Y; Yu Y; Dong GH
    JAMA Netw Open; 2020 Sep; 3(9):e2017507. PubMed ID: 32955574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of dyslipidemia associated with complications in diabetic patients: a nationwide study in Thailand.
    Narindrarangkura P; Bosl W; Rangsin R; Hatthachote P
    Lipids Health Dis; 2019 Apr; 18(1):90. PubMed ID: 30954084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of type 2 diabetes, hypertension, and dyslipidemia in metabolically healthy obese and non-obese.
    Fingeret M; Marques-Vidal P; Vollenweider P
    Nutr Metab Cardiovasc Dis; 2018 Oct; 28(10):1036-1044. PubMed ID: 30139688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyrotropin Levels Are Associated with Cardiometabolic Risk Factors in Euthyroid Adolescents.
    Le TN; Celi FS; Wickham EP
    Thyroid; 2016 Oct; 26(10):1441-1449. PubMed ID: 27599541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular disease risk of type 2 diabetes mellitus and metabolic syndrome: focus on aggressive management of dyslipidemia.
    Falko JM; Moser RJ; Meis SB; Caulin-Glaser T
    Curr Diabetes Rev; 2005 May; 1(2):127-35. PubMed ID: 18220588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular disease and modifiable cardiometabolic risk factors.
    Cannon CP
    Clin Cornerstone; 2007; 8(3):11-28. PubMed ID: 18452839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "If it ain't broke, don't fix it": a commentary on the positive-negative results of the ACCORD Lipid study.
    Tenenbaum A; Fisman EZ
    Cardiovasc Diabetol; 2010 Jun; 9():24. PubMed ID: 20550659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevalence of dyslipidemia and normal blood lipids level in Uygur population in Kashgar area of Xinjiang Uygur Autonomous Region].
    Zhang ZB; Xue ZX; Wu XJ; Wang TM; Li YH; Song XL; Chao XF; Wang G; Nazibam N; Ayxamgul B; Gulbahar E; Zhou ZY; Sun BS; Wang YZ; Wang M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jun; 38(6):702-708. PubMed ID: 28647967
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduced Lean Body Mass and Cardiometabolic Diseases in Adult Males with Overweight and Obesity: A Pilot Study.
    Khazem S; Itani L; Kreidieh D; El Masri D; Tannir H; Citarella R; El Ghoch M
    Int J Environ Res Public Health; 2018 Dec; 15(12):. PubMed ID: 30563167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.
    Jellinger PS; Handelsman Y; Rosenblit PD; Bloomgarden ZT; Fonseca VA; Garber AJ; Grunberger G; Guerin CK; Bell DSH; Mechanick JI; Pessah-Pollack R; Wyne K; Smith D; Brinton EA; Fazio S; Davidson M
    Endocr Pract; 2017 Apr; 23(Suppl 2):1-87. PubMed ID: 28437620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into the pathophysiology of dyslipidemia in type 2 diabetes.
    Taskinen MR; Borén J
    Atherosclerosis; 2015 Apr; 239(2):483-95. PubMed ID: 25706066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of metabolic disturbances among women with polycystic ovary syndrome in different regions of Brazil.
    Maffazioli GDN; Lopes CP; Heinrich-Oliveira V; Lobo RA; Hayashida SAY; Soares JM; Maciel GAR; Baracat EC
    Int J Gynaecol Obstet; 2020 Dec; 151(3):383-391. PubMed ID: 32931592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study.
    Halcox JP; Banegas JR; Roy C; Dallongeville J; De Backer G; Guallar E; Perk J; Hajage D; Henriksson KM; Borghi C
    BMC Cardiovasc Disord; 2017 Jun; 17(1):160. PubMed ID: 28623902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Wrist Circumference and Waist-to-Height Ratio with Cardiometabolic Risk Factors among Type II Diabetics in a Ghanaian Population.
    Obirikorang C; Obirikorang Y; Acheampong E; Anto EO; Toboh E; Asamoah EA; Amakwaa B; Batu EN; Brenya P
    J Diabetes Res; 2018; 2018():1838162. PubMed ID: 29670914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.